Evidence Hub

Xanthogranulomatous prostatitis: A case report

Yang J, Zhu YY, Li SJ

Urology case reports, 2026

Abstract

Xanthogranulomatous Prostatitis (XGP) is a rare benign inflammatory condition of the prostate. Patients typically present with lower urinary tract symptoms or elevated serum prostate-specific antigen (PSA) levels. Differentiating XGP from prostate cancer (PCa) based solely on multiparametric MRI (mpMRI) findings remains challenging, as histopathological examination is the gold standard for definitive diagnosis. This case report describes a 57-year-old man diagnosed with XGP. Symptomatic remission was achieved following a 4-week course of antibiotic therapy combined with an alpha-blocker.

How strong is the evidence?

Evidence Hub reads this as a case report, done in people. Its evidence level is 5 of 5 (Very low · case / narrative / animal / in vitro / in silico). Case reports, narrative reviews, and animal, cell or computer-model studies give the weakest evidence for human health.

How the five levels of evidence work. The level is assigned automatically from the abstract and can be wrong, so check the paper.

Read the paper

Related studies

Go deeper in Evidence Hub

Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.

Open this study Sign up free